I don't know if the new preclinical trial is going well or not but what I do know is that Dr. Chan is coming up on 9 months since taking his first dose of LL and he's still alive (as of 3/11/25). I don't know much about GBM but he has GBM IDH-wild type which is a particularly aggressive type apparently and his tumor was spread to both hemispheres of the brain. His case appears promising that our drug is able to help in this terrible condition. Hopefully we are able to see it in the follow-up preclinical study as well.